心源性休克：概述。

IF 1 Q4 CRITICAL CARE MEDICINE Critical Care Nursing Quarterly Pub Date : 2024-07-01 Epub Date: 2024-06-07 DOI:10.1097/CNQ.0000000000000513

Mohamed Toufic El Hussein, Camila Mushaluk

{"title":"心源性休克：概述。","authors":"Mohamed Toufic El Hussein, Camila Mushaluk","doi":"10.1097/CNQ.0000000000000513","DOIUrl":null,"url":null,"abstract":"Cardiogenic shock (CS) is a complex and dreadful condition for which effective treatments remain unclear. The concerningly high mortality rate of CS emphasizes a need for developing effective therapies to reduce its mortality and reverse its detrimental course. This article aims to provide an updated and evidence-based review of the pathophysiology of CS and the related pharmacotherapeutics with a special focus on vasoactive and inotropic agents.","PeriodicalId":10789,"journal":{"name":"Critical Care Nursing Quarterly","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cardiogenic Shock: An Overview.\",\"authors\":\"Mohamed Toufic El Hussein, Camila Mushaluk\",\"doi\":\"10.1097/CNQ.0000000000000513\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cardiogenic shock (CS) is a complex and dreadful condition for which effective treatments remain unclear. The concerningly high mortality rate of CS emphasizes a need for developing effective therapies to reduce its mortality and reverse its detrimental course. This article aims to provide an updated and evidence-based review of the pathophysiology of CS and the related pharmacotherapeutics with a special focus on vasoactive and inotropic agents.\",\"PeriodicalId\":10789,\"journal\":{\"name\":\"Critical Care Nursing Quarterly\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical Care Nursing Quarterly\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CNQ.0000000000000513\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/6/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical Care Nursing Quarterly","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CNQ.0000000000000513","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/7 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}

引用次数: 0

摘要

心源性休克（CS）是一种复杂而可怕的疾病，其有效治疗方法尚不明确。CS 的死亡率之高令人担忧，因此需要开发有效的疗法来降低死亡率并扭转其有害的病程。本文旨在对 CS 的病理生理学和相关药物治疗进行最新的循证综述，并特别关注血管活性药物和肌力药物。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Cardiogenic Shock: An Overview.

Cardiogenic shock (CS) is a complex and dreadful condition for which effective treatments remain unclear. The concerningly high mortality rate of CS emphasizes a need for developing effective therapies to reduce its mortality and reverse its detrimental course. This article aims to provide an updated and evidence-based review of the pathophysiology of CS and the related pharmacotherapeutics with a special focus on vasoactive and inotropic agents.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Critical Care Nursing Quarterly CRITICAL CARE MEDICINE-

CiteScore

2.60

自引率

0.00%

发文量

期刊介绍： Critical Care Nursing Quarterly (CCNQ) is a peer-reviewed journal that provides current practice-oriented information for the continuing education and improved clinical practice of critical care professionals, including nurses, physicians, and allied health care professionals.